| Prev Close | 179.51 |
| Open | 195.80 |
| Day Low/High | 189.13 / 198.00 |
| 52 Wk Low/High | 108.85 / 209.00 |
| Volume | 437.96K |
ResMed Inc. (RMD)
190.34
11.00
6.00
NYSE
| Exchange | NYSE |
| Shares Outstanding | 144.91B |
| Market Cap | 26.18B |
| P/E Ratio | 42.31 |
| Div & Yield | N.A. (N.A) |
Latest News
Upgrades, Downgrades, Initiations
Here we go folks, a sampling of this morning's upgrades, downgrades and initiations. I'll be back with some thought on these after I get another cup of my morning fuel (coffee). Upgrades Sprint by UBS from Neutral to Buy with a $10 price target Res...
ResMed Could Rally Another 25% From Here
Here's how to play the stock now.
ResMed Investors Should Not Fall Asleep With Their Investments
Let's check over the charts and indicators of ResMed.
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Markets Take the Government Shutdown in Their Stride: Market Recon
Although equity index futures are lower, this whole thing has been taken in stride. For now.
How to Play Eight Potential Breakout Stocks
A partial list of names that are showing signs of breaking out Monday.
Why CarMax and Garmin Could Be Prime Candidates for a Short Squeeze
Short-sellers are feeling the pressure this year, but you don't have to if you take a look at these four stock that could face short squeezes.
Are ResMed Shares About to Awaken?
Shares of the maker of sleep-apnea devices are poised to rise and shine.
Market Wrap: Retail Takes Its Toll
April report doesn't impress as averages have little to show.
Screening Major Institutions
Use stock lists as a source for trading ideas to pursue.
Earnings Results Could Wake ResMed Up
A positive report could help this maker of sleep-disorder products break out of its current consolidation.
Three Speculative Earnings Plays
These stocks have high short interest and could see some covering.
On Sleeping Like a Baby
This name, which makes sleeping-disorder treatements, is a solid investment that should allow for some shut-eye.
